The parasite clearance curve

Parasite clearance rates are important measures of anti-malarial drug efficacy. They are particularly important in the assessment of artemisinin resistance. The slope of the log-linear segment in the middle of the parasite clearance curve has the least inter-individual variance and is the focus of therapeutic assessment. The factors affecting parasite clearance are reviewed. Methods of presentation and the approaches to analysis are discussed.

• Publication year

  2011

• Venue

  Malaria Journal

• Publication date

  2011-09-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/1475-2875-10-278PMID 21939506PMCID 3195204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers

  2011cited by this paper
• Standardised versus actual white cell counts in estimating thick film parasitaemia in African children under five

  2011cited by this paper
• Inferred relatedness and heritability in malaria parasites

  2010cited by this paper
• Intrahost modeling of artemisinin resistance in Plasmodium falciparum

  2010cited by this paper
• In vivo parasitological measures of artemisinin susceptibility.

  2010cited by this paper
• High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia.

  2010cited by this paper
• Assessing agreement between malaria slide density readings

  2010cited by this paper
• Artemisinin resistance in Plasmodium falciparum malaria.

  2009cited by this paper
• Pilot assessment of the sensitivity of the malaria thin film

  2008cited by this paper
• Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies

  2008cited by this paper
• Evidence of artemisinin-resistant malaria in western Cambodia.

  2008cited by this paper
• Comparative analysis of malaria parasite density using actual and assumed white blood cell counts

  2007cited by this paper
• Rectal versus intravenous quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomized, double-blind clinical trial.

  2007cited by this paper
• Systematic comparison of two methods to measure parasite density from malaria blood smears

  2006cited by this paper
• Estimation of the Total Parasite Biomass in Acute Falciparum Malaria from Plasma PfHRP2

  2005cited by this paper
• Sources of variability in determining malaria parasite density by microscopy.

  2005cited by this paper
• Stage-specific activity of potential antimalarial compounds measured in vitro by flow cytometry in comparison to optical microscopy and hypoxanthine uptake.

  2004cited by this paper
• Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes

  2002cited by this paper
• Central role of the spleen in malaria parasite clearance.

  2002cited by this paper
• Contribution of humoral immunity to the therapeutic response in falciparum malaria.

  2001cited by this paper
• The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.

  2000cited by this paper
• Estimating sequestered parasite population dynamics in cerebral malaria.

  1998cited by this paper
• Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

  1997influential reference
• A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria.

  1996cited by this paper
• Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria.

  1996cited by this paper
• Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum.

  1996cited by this paper
• Statistics Notes: Measurement error proportional to the mean

  1996cited by this paper
• Parasite viability during treatment of severe falciparum malaria: differential effects of artemether and quinine.

  1995cited by this paper
• Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.

  1994cited by this paper
• Efficient assessment of filariasis endemicity by screening for filarial antigenaemia in a sentinel population.

  1994cited by this paper
• Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria.

  1993cited by this paper
• Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria.

  1993cited by this paper
• The effects of multiplication and synchronicity on the vascular distribution of parasites in falciparum malaria.

  1992cited by this paper
• Prognostic significance of rises in parasitaemia during treatment of falciparum malaria.

  1992cited by this paper
• Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens.

  1991cited by this paper
• Comparison of two simple methods for determining malaria parasite density.

  1991cited by this paper
• Open comparison of intramuscular chloroquine and quinine in children with severe chloroquine-sensitive falciparum malaria.

  1989cited by this paper
• Treatment of malaria: some considerations and limitations of the current methods of assessment.

  1989influential reference
• [Development state of Plasmodium falciparum in the intradermal, peripheral and medullary blood of cerebral malaria patients].

  1983cited by this paper
• [Development state of Plasmodium falciparum in the intradermal, peripheral and medullary blood of cerebral malaria patients].

  1983cited by this paper
• The Microscopical Diagnosis of Human Malaria. I. A Morphological Study of the Erythrocytic Parasites in Thick Blood Films

  1964cited by this paper
• THE PASSIVE TRANSFER OF HUMAN MALARIAL IMMUNITY.

  1964cited by this paper
• Gamma-Globulin and Acquired Immunity to Human Malaria

  1961cited by this paper
• Sidelights on malaria in man obtained by subinoculation experiments.

  1947cited by this paper
• Enumeration of parasites in the blood of malarial patients

  1932cited by this paper
• Observations on malaria made during treatment of general paralysis

  1924cited by this paper

• Antimalarial drug efficacy and resistance: Insights from northern Uganda.

  2025cites this paper
• Prognosis of isolated hyperparasitemia in adults with imported severe malaria.

  2025cites this paper
• Detection of novel Plasmodium falciparum haplotypes under treatment pressure in paediatric severe malaria

  2025cites this paper
• Assessing the chemical interactions and biological effects of a petrochemical and bio-based plastic with a common plastic flame retardant and solvent.

  2024cites this paper
• Artemisinin-resistant malaria

  2024cites this paper
• Gyrodactylus in the spotlight: how exposure to light impacts disease and the feeding behavior of the freshwater tropical guppy (Poecilia reticulata).

  2024cites this paper
• Analysis of bamboo fibres and their associated dye on a freshwater fish host-parasite system

  2024cites this paper
• Defining the next generation of severe malaria treatment: a target product profile

  2024cites this paper
• Temporal genomic analysis of Plasmodium falciparum reveals increased prevalence of mutations associated with delayed clearance following treatment with artemisinin-lumefantrine in Choma District, Southern Province, Zambia

  2024cites this paper
• Application of LAMP assay for detection of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in ICU admitted sepsis patients: A rapid and cost-effective diagnostic tool.

  2024cites this paper
• Temporal genomics in Southern Zambia shows rising prevalence of Plasmodium falciparum mutations linked to delayed clearance after artemisinin-lumefantrine treatment

  2024cites this paper
• Incomplete Plasmodium falciparum growth inhibition following piperaquine treatment translates into increased parasite viability in the in vitro parasite reduction ratio assay

  2024cites this paper
• Driving down Poisson error can offset classification error in clinical tasks

  2024cites this paper
• Evaluation of an automated microscope using machine learning for the detection of malaria in travelers returned to the UK

  2023cites this paper
• A class of their own? Water-soluble polymer pollution impacting a freshwater host-pathogen system.

  2023cites this paper
• The impacts of synthetic and cellulose-based fibres and their associated dyes on fish hosts and parasite health

  2023cites this paper
• Therapeutic efficacy of pyronaridine-artesunate (Pyramax®) against uncomplicated Plasmodium falciparum infection at Hamusit Health Centre, Northwest Ethiopia

  2023cites this paper
• The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro

  2023cites this paper
• Pathogenetic mechanisms and treatment targets in cerebral malaria

  2023cites this paper
• Plasmodium 18S Ribosomal RNA Biomarker Clearance After Food and Drug Administration–Approved Antimalarial Treatment in Controlled Human Malaria Infection Trials

  2023cites this paper
• Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria

  2023cites this paper
• Dihydroartemisinin-piperaquine efficacy in Plasmodium falciparum treatment and prevalence of drug-resistant molecular markers along China-Myanmar border in 2014-2023.

  2023cites this paper
• Low Complexity of Infection Is Associated With Molecular Persistence of Plasmodium falciparum in Kenya and Tanzania

  2022cites this paper
• Use case-focused metrics to evaluate machine learning for diseases involving parasite loads

  2022cites this paper
• Targeting malaria parasites inside mosquitoes: ecoevolutionary consequences

  2022cites this paper
• Differential effects of two prevalent environmental pollutants on host-pathogen dynamics.

  2022cites this paper
• Optical Spectrophotometry as a Promising Method for Quantification and Stage Differentiation of Plasmodium falciparum Parasites.

  2022cites this paper
• A single low dose of primaquine is safe and sufficient to reduce transmission of Plasmodium falciparum gametocytes regardless of cytochrome P450 2D6 enzyme activity in Bagamoyo district, Tanzania

  2022cites this paper
• Metrics to guide development of machine learning algorithms for malaria diagnosis

  2022cites this paper
• Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment

  2022cites this paper
• Current methods for the detection of antimalarial drug resistance in Plasmodium parasites infecting humans.

  2021cites this paper
• Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria

  2021cites this paper
• Artemisinin-resistant K13 mutations rewire Plasmodium falciparum’s intra-erythrocytic metabolic program to enhance survival

  2021cites this paper
• Pitting of malaria parasites in microfluidic devices mimicking spleen interendothelial slits

  2021cites this paper
• Artemether–lumefantrine and dihydroartemisinin–piperaquine treatment outcomes among children infected with uncomplicated Plasmodium falciparum malaria in Mwanza, Tanzania

  2021cites this paper
• Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with <named-content content-type='genus-species'>Plasmodium falciparum</named-content> Blood-Stage Malaria

  2021cites this paper
• Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study

  2021cites this paper
• Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination

  2021cites this paper
• Pharmacokinetic Study of Rectal Artesunate in Children with Severe Malaria in Africa

  2021cites this paper
• Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations

  2021cites this paper
• Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria.

  2020cites this paper
• Genomic Approaches to Drug Resistance in Malaria.

  2020cites this paper
• Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?

  2020cites this paper
• Towards harmonization of microscopy methods for malaria clinical research studies

  2020cites this paper
• Noise pollution: acute noise exposure increases susceptibility to disease and chronic exposure reduces host survival

  2020cites this paper
• Malaria Parasite Clearance: What Are We Really Measuring?

  2020cites this paper
• Ensemble modeling highlights importance of understanding parasite-host behavior in preclinical antimalarial drug development

  2020cites this paper
• Evaluation of residual submicroscopic Plasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy

  2020cites this paper
• Parasite viability is a superior measure of anti-malarial drug activity in humans.

  2020cites this paper
• Efficacy and resistance of different artemisinin-based combination therapies: a systematic review and network meta-analysis.

  2020cites this paper
• Design and tests of prospective property predictions for novel antimalarial 2-aminopropylaminoquinolones

  2020cites this paper
• Therapeutic Efficacy of Artemether-Lumefantrine for Uncomplicated Falciparum Malaria in Northern Zambia.

  2020cites this paper
• A Bayesian approach to compare the effect of three drugs used to treat children suffering from malaria

  2020cites this paper
• Diversity and Drug Resistance in Plasmodium falciparum Malaria Infections

  2020cites this paper
• Noise Pollution

  2020cites this paper
• Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error

  2020cites this paper
• Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether–lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial

  2020cites this paper
• fish stressor : mechanical disturbance during transportation impacts susceptibility to 1 disease in a globally important ornamental fish 2 3

  2019cites this paper
• Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance

  2019cites this paper
• K13-propeller gene polymorphisms of Plasmodium falciparum and the therapeutic effect of artesunate among migrant workers returning to Guangxi, China (2014–2017)

  2019cites this paper
• Fully-automated patient-level malaria assessment on field-prepared thin blood film microscopy images

  2019cites this paper
• Prevalence of and Risk Factors Associated with Polymerase Chain Reaction-Determined Plasmodium falciparum Positivity on Day 3 after Initiation of Artemether–Lumefantrine Treatment for Uncomplicated Malaria in Bagamoyo District, Tanzania

  2019cites this paper
• Viability Screen of LOPAC1280 Reveals Tyrosine Kinase Inhibitor Tyrphostin A9 as a Novel Partner Drug for Artesunate Combinations To Target the Plasmodium falciparum Ring Stage

  2019cites this paper
• Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial

  2019cites this paper
• In Vivo Assessments to Detect Antimalarial Resistance.

  2019cites this paper
• Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a WWARN individual patient data meta-analysis

  2019cites this paper
• Ensemble machine learning modeling for the prediction of artemisinin resistance in malaria

  2019cites this paper
• Genetic diversity and drug resistance surveillance of Plasmodium falciparum for malaria elimination: is there an ideal tool for resource-limited sub-Saharan Africa?

  2019cites this paper
• A neglected fish stressor: mechanical disturbance during transportation impacts susceptibility to disease in a globally important ornamental fish.

  2019cites this paper
• Severe malaria

  2019cites this paper
• Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives

  2019cites this paper
• Reactivation of Plasmodium infection during a treatment with Infliximab: a case report.

  2019cites this paper
• Pharmacological and analytical aspects of artemisinin for malaria: Advances and challenges

  2019cites this paper
• Assessment of lipid profile and kidney function biomarkers in Plasmodium berghei infected mice treated with artemisinin-based combination therapy

  2019influential citation
• Machine learning for randomised controlled trials: identifying treatment effectheterogeneity with strict control of type I error

  2018cites this paper
• D EFINING THE P OWER AND L IMITS OF AN A PPROACH FOR D ETECTING D RUG R ESISTANCE IN P OLYCLONAL P LASMODIUM FALCIPARUM INFECTIONS

  2018cites this paper
• Predicting the duration of antimalarial treatment with heme degradation inhibitors of blood schizonticides using mathematical models

  2018cites this paper
• Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination

  2018cites this paper
• Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance

  2018influential citation
• Within‐host modeling of blood‐stage malaria

  2018cites this paper
• Within-host modelling of blood-stage malaria

  2018cites this paper
• Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar

  2018cites this paper
• A Comparison of Different Parasitaemia Levels on Malaria Transmission Post-asexual Drug Treatment

  2018cites this paper
• Development of a High-Throughput Magnetic Separation Device for Malaria-Infected Erythrocytes

  2017cites this paper
• Complicated malaria in children and adults from three settings of the Colombian Pacific Coast: A prospective study

  2017cites this paper
• Sustained High Cure Rate of Artemether-Lumefantrine against Uncomplicated Plasmodium falciparum Malaria after 8 Years of Its Wide-Scale Use in Bagamoyo District, Tanzania.

  2017cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 239 Modelling and Simulation to Improve Antimalarial Therapy

  2017cites this paper
• Novel phenotypic assays detect artemisinin-resistant Plasmodium falciparum malaria in Cambodia : in-vitro and ex-vivo drug response studies Running title : In-vitro and ex-vivo detection of artemisinin resistance

  2017cites this paper
• How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria.

  2017cites this paper
• Computer-Automated Malaria Diagnosis and Quantitation Using Convolutional Neural Networks

  2017cites this paper
• Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort

  2017cites this paper
• Associations between IgG antibody responses to multiple Plasmodium falciparum antigens and treatment outcomes with ACTs in Man, Cote d’Ivoire

  2017cites this paper
• Population genetics of Plasmodium falciparum parasites exposed to artemisinin treatment in patients taking part in an efficacy clinical trial in Kisumu county, western Kenya.

  2017cites this paper
• Predicting the Duration of Chloroquine, Mefloquine, Halfantrine and Artesunate for Blood Schizonticidal Effect using Mathematical Models of Malaria with Immune Response

  2017cites this paper
• Immunity as a predictor of anti-malarial treatment failure: a systematic review

  2017cites this paper
• Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria

  2017cites this paper
• Adaptive immunity is essential in preventing recrudescence of Plasmodium yoelii malaria parasites after artesunate treatment

  2017cites this paper
• Malaria parasite clearance

  2017influential citation
• Plasmodium falciparum et résistance aux antipaludiques : aperçu et conséquences des facteurs impliqués dans la sélection et la diffusion des parasites résistants

  2017cites this paper
• In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination Strategies

  2017cites this paper